AARD (STOCKS)
Aardvark Therapeutics, Inc. Common Stock
$12.670000
+0.060000 (+0.48%)
Prev close: $12.610000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Tien Li Lee
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $276.41M
- Employees
- 31
- P/E (TTM)
- -5.61
- P/B (TTM)
- 2.24
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.75 | $-0.81 | +0.0645 | +7.92% |
|
Jun 2025 (Q2)
|
$-0.66 | $-0.61 | -0.0480 | -7.84% |
|
Mar 2025 (Q1)
|
$-0.71 | $-0.69 | -0.0232 | -3.38% |
Financial Statements
| Assets | $133.23M |
| Current Assets | $129.21M |
| Cash | $126.40M |
| Other Current Assets | $2.81M |
| Noncurrent Assets | $4.02M |
| Liabilities | $10.85M |
| Current Liabilities | $10.74M |
| Accounts Payable | $4.44M |
| Wages | $2.15M |
| Other Current Liabilities | $4.14M |
| Noncurrent Liabilities | $116.00K |
| Equity | $122.38M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $122.38M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $133.23M |